Tiffany, Kors to Re...
Health Care: Drugs
Cardiome Pharma Corporation (CRME: NASDAQ)
$1.94 0.00 | 0.00%
05/24/13 - 03:59 PM ET
Company Balance Sheet
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 41.27M | 48.64M | 76.89M | 47.45M |
| Receivables | 978.00K | 1.25M | 732.00K | 1.43M |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 43.02M | 50.52M | 78.62M | 49.38M |
| Property, Plant & Equipment, Gross | 782.00K | 8.40M | 8.51M | 8.46M |
| Accumulated Depreciation & Depletion | 511.00K | 6.44M | 6.44M | 5.81M |
| Property, Plant & Equipment, Net | 271.00K | 1.97M | 2.07M | 2.66M |
| Intangibles | 1.51M | 1.55M | 1.64M | 15.58M |
| Other Non-Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Assets | 1.78M | 3.52M | 3.70M | 18.24M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 44.79M | 54.04M | 82.32M | 67.61M |
| Accounts Payable | 1.04M | 351.00K | 5.70M | 7.65M |
| Short Term Debt | 32.50M | 116.00K | 216.00K | 212.97K |
| Other Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Liabilities | 36.93M | 3.30M | 5.92M | 43.19M |
| Long Term Debt | 0.00 | 25.00M | 25.00M | 0.00 |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 0.00 | 25.44M | 25.49M | 699.07K |
| Total Liabilities | 36.93M | 28.75M | 31.41M | 43.89M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 7.86M | 25.29M | 50.92M | 23.72M |
| Common Par | 0.00 | 0.00 | 0.00 | 0.00 |
| Additional Paid In Capital | 295.19M | 294.30M | 292.02M | 339.53M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -305.52M | -287.20M | -259.28M | -315.80M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | 18.18M | 18.18M | 18.18M | 0.00 |
| Total Capitalization | 7.86M | 50.29M | 75.92M | 23.72M |
| Total Equity | 7.86M | 25.29M | 50.92M | 23.72M |
| Total Liabilities & Stock Equity | 44.79M | 54.04M | 82.32M | 67.61M |
| Total Common Shares Outstanding | 12.47M | 12.23M | 12.21M | 12.10M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 12.25M | 12.23M | 12.16M | 12.65M |
| Diluted Weighted Shares Outstanding | 12.25M | 12.23M | 12.26M | 12.65M |
| Number of Employees | 13 | 92 | 79 | 84 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with CRME
- Portfolio NameUser Type
- ContributorStocks Under-$10 Setting Up...
- UserUBS Portfoglio Fall 2008
- UserKathleen Futey Portfolio 1
- Userkimtdallas Portfolio 1
- ContributorStockerblog.com Canadian Li...
- Usergrtdane Portfolio 1
- Userjack stern Portfolio 1
- Userpanda33 Portfolio 1
- UserJRT Portfolio 1
- Userirvgruve Portfolio 1
Latest CRME Headlines from TheStreet
- Cardiome Reaches Agreement With Merck To Retire Debt And Close Line Of Credit 12.11.12 | 08:12 am
- Cardiome To Hold Conference Call 09.26.12 | 08:09 am
- Merck Returns Global Marketing And Development Rights For Vernakalant To Cardiome 09.26.12 | 08:09 am
- Cardiome Announces Appointment Of Jennifer Archibald As Chief Financial Officer 09.20.12 | 04:09 pm
- Cardiome Notes Updated Guidelines From European Society Of Cardiology Now Include Brinavess(TM) (Vernakalant) For Infusion 09.10.12 | 08:09 am
- Cardiome To Hold Investor Update Call 08.21.12 | 04:08 pm
- 5 Under-$10 Stocks Set to Soar 12.29.11 | 06:12 pm
- Cardiome Pharma Corp. (CRME): Today's Featured Health Care Loser 09.29.11 | 04:09 pm
- Cardiome Pharma Corp. Stock Downgraded (CRME) 09.05.11 | 08:09 am
- Cardiome Stock Gaps Up On Today's Open (CRME) 07.26.11 | 09:07 am
Press Releases for CRME
- Cardiome Announces The Addition Of Dr. Steen Juul-Möller As Medical Director, Europe - PR Newswire 03.28.13 | 07:03 am
- Cardiome Announces Changes To Senior Management Team - PR Newswire 03.26.13 | 07:03 pm
- Independent Proxy Advisor Firms ISS And Glass Lewis Recommend Cardiome Shareholders Vote In Favor Of Share Consolidation - PR Newswire 03.19.13 | 04:03 pm
- Cardiome Reports Fourth Quarter And Full Year 2012 Financial Results - PR Newswire 03.15.13 | 07:03 am
- Cardiome To Hold Fourth Quarter And Full Year 2012 Financial Results Conference Call On March 15 - PR Newswire 03.12.13 | 02:03 pm
- Cardiome Announces Settlement Of Debt And Termination Of Line Of Credit With Merck - PR Newswire 03.04.13 | 08:03 am
- Cardiome Selects Quintiles To Manage Global Regulatory Affairs And Life Cycle Safety Activities For BRINAVESSâ¿¢ (Vernakalant Intravenous) - PR Newswire 02.04.13 | 04:02 pm
- Cardiome Announces Management Change - PR Newswire 07.03.12 | 12:07 pm
- CARDIOME REPORTS FIRST QUARTER RESULTS - PR Newswire 05.16.11 | 04:05 pm
- CARDIOME TO PRESENT AT THE BARCLAYS CAPITAL 2011 GLOBAL HEALTHCARE CONFERENCE - PR Newswire 03.15.11 | 03:03 pm
Partner Headlines for CRME
- Cardiome Announces CEO Doug Janzen Has Left Company - Benzinga 07.03.12 | 12:07 pm
- Diana Containerships: High-Yield Dividend Play With Mid-Term Charters - Seeking Alpha 07.03.12 | 09:07 am
- Morning Market Losers - Benzinga 03.19.12 | 09:03 am
- Morning Market Movers - Benzinga 12.29.11 | 09:12 am
- Zacks #5 Rank Additions for Wednesday - Tale of the Tape - Zacks 11.09.11 | 09:11 am
- Zacks #5 Rank Additions for Thursday - Tale of the Tape - Zacks 10.27.11 | 09:10 am
- Zacks #5 Rank Additions for Thursday - Tale of the Tape - Zacks 10.27.11 | 09:10 am
- Zacks #5 Rank Additions for Monday - Tale of the Tape - Zacks 07.11.11 | 09:07 am
- Flat Finish Friday, But Stocks End Week Sharply Lower - Seeking Alpha 06.25.10 | 04:06 pm
- 25 Momentum Stocks for Tuesday - SeekingAlpha.com 04.06.10 | 03:04 am
